Clinical Trial: Retrospective analysis of the efficacy and safety of carfilzomib in the treatment of newly diagnosed high-risk multiple myeloma (China)

Posted On: 2026-08-19

China, Aug. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Retrospective analysis of the efficacy and safety of carfilzomib in the treatment of newly diagnosed high-risk multiple myeloma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130294

Registration Time: 2026/08/18

Type: Observational study

Primary Sponsor: Qilu Hospital of Shandong University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335101

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Retrospective analysis of the efficacy and safety of carfilzomib in the treatment of newly diagnosed high-risk multiple myeloma (China)